Open AccessDownregulation of Tie2 gene by a novel antitumor sulfolipid, 3′‐sulfoquinovosyl‐1′‐monoacylglycerol, targeting angiogenesis
Author(s) -
Mori Yoko,
Sahara Hiroeki,
Matsumoto Kayo,
Takahashi Nobuaki,
Yamazaki Takayuki,
Ohta Keisuke,
Aoki Satoko,
Miura Masahiko,
Sugawara Fumio,
Sakaguchi Kengo,
Sato Noriyuki
Publication year - 2008
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2008.00785.x
Subject(s) - angiogenesis , downregulation and upregulation , in vivo , cancer research , angiopoietin receptor , gene expression , biology , monoacylglycerol lipase , gene , microbiology and biotechnology , biochemistry , receptor , genetics , endocannabinoid system
We previously reported that 3′‐sulfoquinovosyl‐1′‐monoacylglycerol (SQMG) was effective in suppressing the growth of solid tumors due to hemorrhagic necrosis in vivo . In the present study, we investigated the antiangiogenic effect of SQMG. In vivo assessment of antitumor assays showed that some tumor cell lines, but not others, were sensitive to SQMG. Microscopic study suggested that in SQMG‐sensitive tumors, but not SQMG‐resistant tumors, angiogenesis was reduced. We next investigated gene expression relating to angiogenesis in tumor tissues by quantitative real‐time polymerase chain reaction. Consequently, although vascular endothelial growth factor gene expression was not detected with significant differences among the cases, significant downregulation of Tie2 gene expression was observed in all SQMG‐sensitive tumors as compared with controls, but not in SQMG‐resistant tumors. These data suggested that the antitumor effects of SQMG could be attributed to antiangiogenic effects, possibly via the downregulation of Tie2 gene expression in SQMG‐sensitive tumors. ( Cancer Sci 2008; 99: 1063–1070)